open access

Vol 7, No 1 (2022)
Original article
Published online: 2022-03-31
Get Citation

The effect of laparoscopic sleeve gastrectomy on body mass index and obesity-related diseases in patients over 50 years old

Inna Diemieszczyk1, Paulina Głuszyńska1, Piotr Gołaszewski1, Jerzy R. Ładny1, Klaudiusz Nadolny23, Jerzy Łukaszewicz1, Hady Razak Hady1
·
Medical Research Journal 2022;7(1):61-65.
Affiliations
  1. I Department of General Surgery, Bialystok, Poland
  2. Faculty of Medicine, Katowice School of Technology, Katowice, Poland
  3. 3 Department of Health Sciences, WSB University, Dabrowa Gornicza, Poland

open access

Vol 7, No 1 (2022)
ORIGINAL ARTICLES
Published online: 2022-03-31

Abstract

Aim of the study: Obesity is a pandemic of the 21st century and may regard people of every age. Persons after 50 years of age are a group especially exposed to severe impact of obesity which is connected, among others, with increased risk of co-morbidities. Along with age, the human body undergoes processes connected with metabolic rate decrease, accumulation of fat tissue, a physical capacity decrease which exacerbates the issue of obesity.

Material and methods: Retrospective analysis of biochemical and clinical parameters was conducted in the group of 102 patients, age 50–66 years old, after sleeve gastrectomy.

Results: During observation, average BMI decreased from 45.52 (41.26–50.87) kg/m2 before the surgery to 29.71 (26.08–35.42) kg/m2 one year after the surgery (p < 0.001). %TWL 12 months after LSG reached 33.91% (27.81–37.6%) (p < 0.001), average % EBMIL was 76.78% (58.71–93.08%). The study revealed that the most frequently coexisting diseases with obesity were: hypertension (89 patients), type 2 diabetes (39 patients), sleep apnea (27 patients), and dyslipidemia (25 patients). One year follow-up revealed remission of hypertension in 37 patients (41.57%), type 2 diabetes in 16 patients (41.02%), sleep apnea in 12 patients (44.44%), and dyslipidemia in 19 patients (76%). In patients after LSG, improvement of biochemical parameters including lipid and carbohydrate balance, as well as improvement or recovery from co-morbidities were observed.

Conclusions: LSG is an efficient method of obesity treatment, especially for patients after 50 years old with co-morbidities, which leads to permanent body mass loss as well as remission or recovery from chronic diseases and improves the quality of life.

Abstract

Aim of the study: Obesity is a pandemic of the 21st century and may regard people of every age. Persons after 50 years of age are a group especially exposed to severe impact of obesity which is connected, among others, with increased risk of co-morbidities. Along with age, the human body undergoes processes connected with metabolic rate decrease, accumulation of fat tissue, a physical capacity decrease which exacerbates the issue of obesity.

Material and methods: Retrospective analysis of biochemical and clinical parameters was conducted in the group of 102 patients, age 50–66 years old, after sleeve gastrectomy.

Results: During observation, average BMI decreased from 45.52 (41.26–50.87) kg/m2 before the surgery to 29.71 (26.08–35.42) kg/m2 one year after the surgery (p < 0.001). %TWL 12 months after LSG reached 33.91% (27.81–37.6%) (p < 0.001), average % EBMIL was 76.78% (58.71–93.08%). The study revealed that the most frequently coexisting diseases with obesity were: hypertension (89 patients), type 2 diabetes (39 patients), sleep apnea (27 patients), and dyslipidemia (25 patients). One year follow-up revealed remission of hypertension in 37 patients (41.57%), type 2 diabetes in 16 patients (41.02%), sleep apnea in 12 patients (44.44%), and dyslipidemia in 19 patients (76%). In patients after LSG, improvement of biochemical parameters including lipid and carbohydrate balance, as well as improvement or recovery from co-morbidities were observed.

Conclusions: LSG is an efficient method of obesity treatment, especially for patients after 50 years old with co-morbidities, which leads to permanent body mass loss as well as remission or recovery from chronic diseases and improves the quality of life.

Get Citation

Keywords

sleeve gastrectomy, obesity, hypertension, dyslipidemia, type 2 diabetes

About this article
Title

The effect of laparoscopic sleeve gastrectomy on body mass index and obesity-related diseases in patients over 50 years old

Journal

Medical Research Journal

Issue

Vol 7, No 1 (2022)

Article type

Original article

Pages

61-65

Published online

2022-03-31

Page views

4705

Article views/downloads

343

DOI

10.5603/MRJ.a2022.0010

Bibliographic record

Medical Research Journal 2022;7(1):61-65.

Keywords

sleeve gastrectomy
obesity
hypertension
dyslipidemia
type 2 diabetes

Authors

Inna Diemieszczyk
Paulina Głuszyńska
Piotr Gołaszewski
Jerzy R. Ładny
Klaudiusz Nadolny
Jerzy Łukaszewicz
Hady Razak Hady

References (20)
  1. Szymaszkiewicz A, Szymaszkiewicz K, Fichna J, et al. Ocena zmian zachodzących wraz z wiekiem w jelitowym układzie nerwowym i ich wpływ na perystaltykę przewodu pokarmowego. Postępy Biochemii. 2021; 67(1): 34–43.
  2. Calder PC, Bosco N, Bourdet-Sicard R, et al. Health relevance of the modification of low grade inflammation in ageing (inflammageing) and the role of nutrition. Ageing Res Rev. 2017; 40: 95–119.
  3. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol. 2004; 39(5): 687–699.
  4. Marques A, Peralta M, Naia A, et al. Prevalence of adult overweight and obesity in 20 European countries, 2014. Eur J Public Health. 2018; 28(2): 295–300.
  5. Stepaniak U, Micek A, Waśkiewicz A, et al. Prevalence of general and abdominal obesity and overweight among adults in Poland. Results of the WOBASZ II study (2013-2014) and comparison with the WOBASZ study (2003-2005). Pol Arch Med Wewn. 2016; 126(9): 662–671.
  6. European Commission. Statistics Eurostat: Obesity rate by body mass index (BMI). https://ec.europa.eu/eurostat/databrowser/view/sdg_02_10/default/table?lang=en (08.01.2022).
  7. Jarzynkowski P, Książek J, Piotrkowska R. Surgical treatment of obesity: the role and tasks of the interdisciplinary team. Nursing and Public Health. 2016; 6(4): 323–329.
  8. Diemieszczyk I, Woźniewska P, Gołaszewski P, et al. Does weight loss after laparoscopic sleeve gastrectomy contribute to reduction in blood pressure? Pol Arch Intern Med. 2021; 131(7-8): 693–700.
  9. Fried M, Yumuk V, Oppert JM, et al. International Federation for the Surgery of Obesity and Metabolic Disorders - European Chapter, International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC), European Association for the Study of Obesity (EASO). Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg. 2014; 24(1): 42–55.
  10. National Task Force on the Prevention and Treatment of Obesity. Overweight, obesity, and health risk. Arch Intern Med. 2000; 160(7): 898–904.
  11. Villareal DT, Apovian CM, Kushner RF, et al. American Society for Nutrition, NAASO, The Obesity Society, American Society for Nutrition, NAASO, The Obesity Society. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am J Clin Nutr. 2005; 82(5): 923–934.
  12. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006; 295(13): 1549–1555.
  13. Medonet. https://www.medonet.pl/strefa-mamy-i-dziecka/dbam-o-zdrowie-dziecka-i-rodziny, otylosc-wsrod-dzieci---powazny-problem--ktory-generuje-kolejne, artykul, 50415210.html (08.01.2022).
  14. Hady HR, Wojciak P, Pawluszewicz P, et al. Laparoscopic sleeve gastrectomy (LSG) as a operative method of morbid obesity treatment and resolution of its comorbidities. Postępy Nauk Medycznych. 2018(2): 81–88.
  15. Haase CL, Eriksen KT, Lopes S, et al. Body mass index and risk of obesity-related conditions in a cohort of 2.9 million people: Evidence from a UK primary care database. Obes Sci Pract. 2021; 7(2): 137–147.
  16. Tam BT, Morais JA, Santosa S. Obesity and ageing: Two sides of the same coin. Obes Rev. 2020; 21(4): e12991.
  17. Woźniewska P, Diemieszczyk I, Hady HR. Complications associated with laparoscopic sleeve gastrectomy — a review. Prz Gastroenterol. 2021; 16(1): 5–9.
  18. Williams S, Cunningham E, Pories WJ. Surgical treatment of metabolic syndrome. Med Princ Pract. 2012; 21(4): 301–309.
  19. Wojciak PA, Pawłuszewicz P, Diemieszczyk I, et al. Laparoscopic sleeve gastrectomy: a study of efficiency in treatment of metabolic syndrome components, comorbidities and influence on certain biochemical markers. Wideochir Inne Tech Maloinwazyjne. 2020; 15(1): 136–147.
  20. Luppi CRO, Balagué C, Targarona EM, et al. Laparoscopic sleeve gastrectomy in patients over 60 years: impact of age on weight loss and co-morbidity improvement. Surg Obes Relat Dis. 2015; 11(2): 296–301.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl